annual EBITDA:
-$271.59M-$67.05M(-32.78%)Summary
- As of today (September 7, 2025), COGT annual EBITDA is -$271.59 million, with the most recent change of -$67.05 million (-32.78%) on December 31, 2024.
- During the last 3 years, COGT annual EBITDA has fallen by -$198.03 million (-269.21%).
- COGT annual EBITDA is now -4134.96% below its all-time high of -$6.41 million, reached on December 31, 2015.
Performance
COGT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$72.06M+$1.74M(+2.35%)Summary
- As of today (September 7, 2025), COGT quarterly EBITDA is -$72.06 million, with the most recent change of +$1.74 million (+2.35%) on June 30, 2025.
- Over the past year, COGT quarterly EBITDA has dropped by -$14.19 million (-24.52%).
- COGT quarterly EBITDA is now -2921.38% below its all-time high of $2.55 million, reached on December 31, 2019.
Performance
COGT quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$292.80M-$14.19M(-5.09%)Summary
- As of today (September 7, 2025), COGT TTM EBITDA is -$292.80 million, with the most recent change of -$14.19 million (-5.09%) on June 30, 2025.
- Over the past year, COGT TTM EBITDA has dropped by -$57.43 million (-24.40%).
- COGT TTM EBITDA is now -4956.05% below its all-time high of -$5.79 million, reached on March 31, 2017.
Performance
COGT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
COGT EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -32.8% | -24.5% | -24.4% |
3 y3 years | -269.2% | -104.8% | -165.1% |
5 y5 years | -779.4% | -912.5% | -1223.3% |
COGT EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -269.2% | at low | -117.6% | +3.0% | -165.1% | at low |
5 y | 5-year | -779.4% | at low | -912.5% | +3.0% | -1323.0% | at low |
alltime | all time | -4135.0% | at low | -2921.4% | +3.0% | -4956.1% | at low |
COGT EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | -$72.06M(-2.4%) | -$292.80M(+5.1%) |
Mar 2025 | - | -$73.80M(+1.6%) | -$278.61M(+4.7%) |
Dec 2024 | -$271.59M(+32.8%) | -$72.63M(-2.3%) | -$266.15M(+6.1%) |
Sep 2024 | - | -$74.32M(+28.4%) | -$250.96M(+6.6%) |
Jun 2024 | - | -$57.87M(-5.7%) | -$235.37M(+5.4%) |
Mar 2024 | - | -$61.34M(+6.8%) | -$223.37M(+9.2%) |
Dec 2023 | -$204.54M(+44.1%) | -$57.43M(-2.2%) | -$204.54M(+7.7%) |
Sep 2023 | - | -$58.73M(+28.0%) | -$189.92M(+15.6%) |
Jun 2023 | - | -$45.87M(+7.9%) | -$164.30M(+7.0%) |
Mar 2023 | - | -$42.51M(-0.7%) | -$153.62M(+8.2%) |
Dec 2022 | -$141.96M(+93.0%) | -$42.81M(+29.3%) | -$141.96M(+14.3%) |
Sep 2022 | - | -$33.11M(-5.9%) | -$124.25M(+12.5%) |
Jun 2022 | - | -$35.19M(+14.0%) | -$110.44M(+20.5%) |
Mar 2022 | - | -$30.86M(+23.0%) | -$91.64M(+24.6%) |
Dec 2021 | -$73.56M(+112.8%) | -$25.09M(+30.0%) | -$73.56M(+22.8%) |
Sep 2021 | - | -$19.30M(+17.9%) | -$59.91M(+18.0%) |
Jun 2021 | - | -$16.38M(+28.1%) | -$50.77M(+22.3%) |
Mar 2021 | - | -$12.78M(+11.7%) | -$41.51M(+20.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2020 | -$34.57M(+11.9%) | -$11.44M(+12.5%) | -$34.57M(+68.0%) |
Sep 2020 | - | -$10.17M(+42.9%) | -$20.58M(-7.0%) |
Jun 2020 | - | -$7.12M(+21.7%) | -$22.13M(-12.3%) |
Mar 2020 | - | -$5.85M(-328.9%) | -$25.22M(-18.3%) |
Dec 2019 | -$30.89M(-11.0%) | $2.55M(-121.8%) | -$30.89M(-26.6%) |
Sep 2019 | - | -$11.72M(+14.8%) | -$42.09M(+3.6%) |
Jun 2019 | - | -$10.21M(-11.3%) | -$40.62M(+2.8%) |
Mar 2019 | - | -$11.51M(+33.0%) | -$39.52M(+14.0%) |
Dec 2018 | -$34.68M(+38.8%) | -$8.65M(-15.6%) | -$34.68M(+6.4%) |
Sep 2018 | - | -$10.25M(+12.4%) | -$32.60M(+11.6%) |
Jun 2018 | - | -$9.11M(+36.6%) | -$29.23M(+13.0%) |
Mar 2018 | - | -$6.67M(+1.5%) | -$25.86M(+3.5%) |
Dec 2017 | -$24.98M(+37.0%) | -$6.57M(-4.3%) | -$24.98M(+35.7%) |
Sep 2017 | - | -$6.87M(+19.5%) | -$18.41M(+59.5%) |
Jun 2017 | - | -$5.75M(-0.8%) | -$11.54M(+99.2%) |
Mar 2017 | - | -$5.79M | -$5.79M |
Dec 2016 | -$18.24M(+184.4%) | - | - |
Dec 2015 | -$6.41M | - | - |
FAQ
- What is Cogent Biosciences, Inc. annual EBITDA?
- What is the all time high annual EBITDA for Cogent Biosciences, Inc.?
- What is Cogent Biosciences, Inc. annual EBITDA year-on-year change?
- What is Cogent Biosciences, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Cogent Biosciences, Inc.?
- What is Cogent Biosciences, Inc. quarterly EBITDA year-on-year change?
- What is Cogent Biosciences, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Cogent Biosciences, Inc.?
- What is Cogent Biosciences, Inc. TTM EBITDA year-on-year change?
What is Cogent Biosciences, Inc. annual EBITDA?
The current annual EBITDA of COGT is -$271.59M
What is the all time high annual EBITDA for Cogent Biosciences, Inc.?
Cogent Biosciences, Inc. all-time high annual EBITDA is -$6.41M
What is Cogent Biosciences, Inc. annual EBITDA year-on-year change?
Over the past year, COGT annual EBITDA has changed by -$67.05M (-32.78%)
What is Cogent Biosciences, Inc. quarterly EBITDA?
The current quarterly EBITDA of COGT is -$72.06M
What is the all time high quarterly EBITDA for Cogent Biosciences, Inc.?
Cogent Biosciences, Inc. all-time high quarterly EBITDA is $2.55M
What is Cogent Biosciences, Inc. quarterly EBITDA year-on-year change?
Over the past year, COGT quarterly EBITDA has changed by -$14.19M (-24.52%)
What is Cogent Biosciences, Inc. TTM EBITDA?
The current TTM EBITDA of COGT is -$292.80M
What is the all time high TTM EBITDA for Cogent Biosciences, Inc.?
Cogent Biosciences, Inc. all-time high TTM EBITDA is -$5.79M
What is Cogent Biosciences, Inc. TTM EBITDA year-on-year change?
Over the past year, COGT TTM EBITDA has changed by -$57.43M (-24.40%)